These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3201096)

  • 41. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome.
    Kalousová M; Novotny L; Zima T; Braun M; Vítek L
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):387-92. PubMed ID: 16309589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of Gilbert-like syndrome in squirrel monkeys (Saimiri sciureus).
    Cornelius CE; Rodgers PA; Bruss ML; Ahlfors CE
    J Med Primatol; 1985; 14(2):59-74. PubMed ID: 3999115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.
    Borlak J; Thum T; Landt O; Erb K; Hermann R
    Hepatology; 2000 Oct; 32(4 Pt 1):792-5. PubMed ID: 11003624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conjugated bilirubin measurements in Gilbert's syndrome: method dependence.
    Thurlow V; Bailey IR; Griffiths W
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):67-9. PubMed ID: 15802037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda.
    Mengistu M; Gebreselassie F; Tsega E
    Ethiop Med J; 1989 Jul; 27(3):107-14. PubMed ID: 2753029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic value of biliary acid serum levels in Gilbert syndrome].
    de la Rubia Fernández L; Arribas Gómez I; del Pozo Vindel F; Pérez Moro A; García de Frías E
    An Esp Pediatr; 1993 Nov; 39(5):395-7. PubMed ID: 8285451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed gastric emptying in subjects with Gilbert's syndrome.
    Méndez-Sánchez N; González V; Flores A; Martínez M; Graef A; Uribe M
    Hepatogastroenterology; 2001; 48(40):1183-5. PubMed ID: 11490829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rifampicin test in the diagnosis of Gilbert's syndrome.
    Erdil A; Kadayifci A; Ates Y; Bagci S; Uygun A; Dagalp K
    Int J Clin Pract; 2001 Mar; 55(2):81-3. PubMed ID: 11321865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unconjugated hyperbilirubinaemia in HBV carriers. Discriminant value of nicotinic acid (NA) test.
    Frezza M; Chiesa L; Zaramella MG; Callegari P; Pozzato G; Pison G; Zalateo C
    Scand J Clin Lab Invest; 1987 Feb; 47(1):63-7. PubMed ID: 3576110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical findings in porphyria cutanea tarda].
    Heilmann E; Vakilzadeh F
    Fortschr Med; 1977 Mar; 95(10):659-61. PubMed ID: 844765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum bile acids in Gilbert's syndrome before and after reduced caloric intake.
    Briheim G; Frydén A; Tobiasson P
    Scand J Gastroenterol; 1982 Oct; 17(7):877-80. PubMed ID: 7156881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron metabolism and its responses to allopurinol treatment in porphyria cutanea tarda.
    Burger T; Horváth T; Jávor T
    Acta Med Acad Sci Hung; 1978; 35(2):115-27. PubMed ID: 742338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ursodeoxycholic acid oral tolerance test in patients with constitutional hyperbilirubinemias and effect of phenobarbital.
    Ohkubo H; Okuda K; Iida S; Makino I
    Gastroenterology; 1981 Jul; 81(1):126-35. PubMed ID: 7239112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda.
    O'Reilly FM; Darby C; Fogarty J; Tormey W; Kay EW; Leader M; Murphy GM
    Arch Dermatol; 1997 Sep; 133(9):1098-101. PubMed ID: 9301586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver transplantation using donors with Gilbert syndrome.
    Kaneko J; Sugawara Y; Maruo Y; Sato H; Tamura S; Imamura H; Kokudo N; Makuuchi M
    Transplantation; 2006 Jul; 82(2):282-5. PubMed ID: 16858293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.